Nat. Rev. Urol. doi: /nrurol

Slides:

Advertisements

Similar presentations

Tyrosine kinase signalling (review) TGF signalling Notch signalling.

Advertisements

Nat. Rev. Urol. doi: /nrurol

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Nat. Rev. Urol. doi: /nrurol

Figure 4 Types of urinary diversion

Nat. Rev. Urol. doi: /nrurol

Figure 4 Interplay between acute kidney injury (AKI),

Figure 2 Recruitment of experts to the Delphi study

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Nephrol. doi: /nrneph

Figure 1 Cellular processes involved in cancer development

Figure 3 Semantic model of the active surveillance (AS) timeline

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Urol. doi: /nrurol

Figure 1 Key elements of the proposed modified Delphi study

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 2 Schema for the phase II Randomized Observation versus

Figure 1 The development process of the Asian

Figure 1 Differences in bladder cancer between genders

Figure 13 Proposed management of bladder cancer with variant histology

Nat. Rev. Urol. doi: /nrurol

Figure 3 Treatment algorithm for adult infertile men with varicoceles

Figure 3 Algorithm for the determination of the clinical

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Nephrol. doi: /nrneph

Figure 1 Environmental factors contributing to IBD pathogenesis

Figure 6 Image sequence demonstrating coronal cuts on MRI

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Urol. doi: /nrurol

Figure 3 Differences in renal cell carcinoma (RCC) between genders

Figure 3 Challenges for big data applications in cardiovascular care

Figure 3 Template for standard pelvic lymphadenectomy

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Comparison of LDR‑BT, HDR‑BT, and EBRT

Nat. Rev. Urol. doi: /nrurol

the SNP profile using 26 prostate cancer GWAS risk SNPs

Nat. Rev. Urol. doi: /nrurol

Figure 6 Combining population-wide and high-risk strategies

Nat. Rev. Urol. doi: /nrurol

Figure 6 The hexosamine biosynthetic pathway (HBP)

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 A hierarchy of steps need to be

Nat. Rev. Urol. doi: /nrurol

Figure 4 The grey zone between active

Figure 2 Putative mechanisms of action of shockwave therapy for ED

Figure 2 Phenotypes of osteoarthritis

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Algorithm for when to determine PTEN

Figure 1 Infection and resistance in urological practice

Presentation transcript:

Nat. Rev. Urol. doi:10.1038/nrurol.2016.46 Figure 1 Potential mechanisms by which exercise delays the progression of prostate cancer Figure 1 | Potential mechanisms by which exercise delays the progression of prostate cancer. Patients with low-risk prostate cancer are able to delay the progression of their disease by undertaking regular physical exercise. Thus far, the exact mechanisms of this effect have yet to be established; although, some evidence exists for a contribution from a variety of diverse mechanisms. Galvão, D. A. et al. (2016) Enhancing active surveillance of prostate cancer: the potential of exercise medicine Nat. Rev. Urol. doi:10.1038/nrurol.2016.46